Other
Operating And Finance Lease, Right-Of-Use Asset
Moderna Operating And Finance Lease, Right-Of-Use Asset decreased by 2.5% to $742M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.5%, from $811M to $742M. Over 5 years (FY 2020 to FY 2025), Operating And Finance Lease, Right-Of-Use Asset shows an upward trend with a 39.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID:
other_operating_and_finance_lease_right_of_use_asset_592acaHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $579M | $531M | $807M | $825M | $741M | $1.32B | $1.27B | $1.15B | $1.21B | $1.37B | $1.15B | $1.13B | $1.21B | $1.28B | $824M | $811M | $803M | $785M | $761M | $742M |
| QoQ Change | — | -8.3% | +52.0% | +2.2% | -10.2% | +78.4% | -3.9% | -9.5% | +4.9% | +13.3% | -15.9% | -1.7% | +6.6% | +6.4% | -35.7% | -1.6% | -1.0% | -2.2% | -3.1% | -2.5% |
| YoY Change | — | — | — | — | +28.0% | +149.0% | +57.5% | +39.4% | +62.8% | +3.3% | -9.6% | -1.7% | -0.1% | -6.1% | -28.3% | -28.2% | -33.4% | -38.8% | -7.6% | -8.5% |
Range$531M – $1.37B
CAGR+5.4%
Avg YoY Growth+11.1%
Median YoY Growth-3.9%
Current Streak6 quarters decline
Frequently Asked Questions
- What is Moderna's operating and finance lease, right-of-use asset?
- Moderna (MRNA) reported operating and finance lease, right-of-use asset of $742M in Q1 2026.
- How has Moderna's operating and finance lease, right-of-use asset changed year-over-year?
- Moderna's operating and finance lease, right-of-use asset decreased by 8.5% year-over-year, from $811M to $742M.
- What is the long-term trend for Moderna's operating and finance lease, right-of-use asset?
- Over 5 years (2020 to 2025), Moderna's operating and finance lease, right-of-use asset has grown at a 39.3% compound annual growth rate (CAGR), from $145M to $761M.